Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

QuidelOrtho Affirms FY2025 Adj EPS Guidance of $2.07-$2.57 vs $2.40 Est; Affirms FY2025 Sales Guidance of $2.600B-$2.810B vs $2.714B Est

Author: Benzinga Newsdesk | August 05, 2025 04:21pm
QuidelOrtho (NASDAQ:QDEL) affirms FY2025 Adj EPS guidance from $2.07-$2.57 to $2.07-$2.57 vs $2.40 analyst estimate. Affirms FY2025 sales outlook from $2.600 billion-$2.810 billion to $2.600 billion-$2.810 billion vs $2.714 billion estimate.

Posted In: QDEL


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist